Kazutoshi Komiya

1PUBLICATIONS

0CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jul 23, 2019

Discontinuation due to immune-related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non-small cell lung cancer.

Kazutoshi Komiya, Tomomi Nakamura, Tomonori Abe

Pageof 1

Frequent Collaborators

Frequent Collaborators